CRMP5 antibodies in patients with small-cell lung cancer or thymoma

Abstract

The collapsin response mediator protein 5 (CRMP5) antibody is usually associated with paraneoplastic neurological syndrome (PNS) and small-cell lung cancer (SCLC) or thymoma. The objective of this study was to assess the frequency of CRMP5 antibodies in patients with such tumours and to see if the presence of antibodies was associated with prognosis in… (More)
DOI: 10.1007/s00262-007-0369-1

Topics

3 Figures and Tables

Slides referencing similar topics